WuXi Biologics (Cayman), Inc. (WXIBF)
5.38
-0.94
(-14.87%)
USD |
OTCM |
Oct 26, 16:00
WuXi Biologics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Austar Lifesciences Ltd. | -- |
| Agilent Technologies, Inc. | 6.738 |
| Bio-Rad Laboratories, Inc. | 1.388 |
| Bruker Corp. | 3.725 |
| Azenta, Inc. | 1.077 |
Price to Book Value Related Metrics
| PE Ratio | 31.55 |
| PS Ratio | 6.646 |
| PEG Ratio | 0.3014 |
| Price to Free Cash Flow | 35.70 |
| Price | 5.38 |
| Earnings Yield | 3.17% |
| Market Cap | 22.09B |
| PEGY Ratio | 0.3014 |
| Operating PE Ratio | 20.53 |
| Normalized PE Ratio | 33.60 |